Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I De Meester

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|February 1, 1997
The effects of CD26/DPP IV-targeted therapy on acute allograft rejectionS Korom, I De Meester, K Onodera, et al.
European Journal of Immunology|May 16, 1998
Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitorS Struyf, I De Meester, S Scharpé, et al.
Psychoneuroendocrinology|February 1, 1997
Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markersM Maes, I De Meester, R Verkerk, et al.
The Journal of Biological Chemistry|June 8, 2001
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine familyA M Lambeir, P Proost, C Durinx, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 15, 2000
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosaD van West, P Monteleone, A Di Lieto, et al.
Biological Psychiatry|September 15, 1991
Decreased serum dipeptidyl peptidase IV activity in major depressionM Maes, I De Meester, G Vanhoof, et al.
Chemical Immunology|November 7, 1999
The role of CD26/DPP IV in chemokine processingJ Van Damme, S Struyf, A Wuyts, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1993
Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjectsG Vanham, L Kestens, I De Meester, et al.
Clinical Chemistry|September 1, 1994
Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjectsM Maes, S Scharpé, I De Meester, et al.
FEBS Letters|August 26, 1998
Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alphaP Proost, S Struyf, D Schols, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|February 1, 1997
The effects of CD26/DPP IV-targeted therapy on acute allograft rejectionS Korom, I De Meester, K Onodera, et al.
European Journal of Immunology|May 16, 1998
Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitorS Struyf, I De Meester, S Scharpé, et al.
Psychoneuroendocrinology|February 1, 1997
Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markersM Maes, I De Meester, R Verkerk, et al.
The Journal of Biological Chemistry|June 8, 2001
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine familyA M Lambeir, P Proost, C Durinx, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 15, 2000
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosaD van West, P Monteleone, A Di Lieto, et al.
Biological Psychiatry|September 15, 1991
Decreased serum dipeptidyl peptidase IV activity in major depressionM Maes, I De Meester, G Vanhoof, et al.
Chemical Immunology|November 7, 1999
The role of CD26/DPP IV in chemokine processingJ Van Damme, S Struyf, A Wuyts, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1993
Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjectsG Vanham, L Kestens, I De Meester, et al.
Clinical Chemistry|September 1, 1994
Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjectsM Maes, S Scharpé, I De Meester, et al.
FEBS Letters|August 26, 1998
Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alphaP Proost, S Struyf, D Schols, et al.
Pageof 7